WednesdayOct 28, 2020 12:00 pm

Men More Likely to View Face Masks as Infringement on Freedom

According to new research that was published in the “Personality and Individual Differences” journal, both women and men are equally likely to wear face masks during the coronavirus pandemic. However, the study shows that women and men tend to have contrasting reasons for not wearing face masks. Matt C. Howard, an assistant professor at the University of South Alabama, is a researcher involved in this study. His interest in the matter arose after reading a few popular news reports that claimed that men were less likely to wear face masks. This is despite recent research that indicated that both women…

Continue Reading

WednesdayOct 28, 2020 10:00 am

Study Discovers Link Between Dopamine, Serotonin and Decision-Making

For the longest time, serotonin and dopamine have been linked to pleasure and reward. In a pioneer study done by researchers from University College London, findings published in “Neuron” show that these two neuromodulators may be connected to general cognition. This is essentially shaping how people view the world and act on those views. Researchers simultaneously and continuously monitored serotonin and dopamine in human brains. While the two neuromodulators have been studied extensively in animals, it is still challenging for researchers to separate the reinforcement animals receive from the decision-making. This is because animals need to be trained in order…

Continue Reading

TuesdayOct 27, 2020 12:00 pm

Comparison Between Saliva, Swab Coronavirus Tests

From the start of the pandemic, researchers and clinicians have been searching for nasopharyngeal swab alternatives. Tests administered using these swabs are hard to scale up for mass testing, they put health workers in closer contact with individuals who may be infected, and they require more supplies. Saliva has been suggested as an easy and low-cost alternative. However, its accuracy and efficacy remain a point of conflict. Trials of saliva-based tests have been carried out in the field but produced mixed results. These results only make it harder for saliva to be used in the existing testing framework as researchers…

Continue Reading

TuesdayOct 27, 2020 11:25 am

Strategic HCP Partnerships Virtual Summit Networking Hub for Healthcare Professionals

Virtual event set for Wednesday, Nov. 18–Friday, Nov. 20, 2020 Forum for healthcare professionals, executives of healthcare organizations and service providers Three virtual environments — exhibit hall, session areas and network rooms — offer optimal opportunity for engagement Hosted by Lincoln Health Network The Strategic HCP Partnerships Summit — a virtual event this year — is shaping up to be a networking hub for healthcare professionals, executives of healthcare organizations (HCO) and service providers. The three-day event, scheduled for Nov. 18–20, 2020, offers a platform that promises to foster engagement and provide a wealth of opportunity to build and expand…

Continue Reading

TuesdayOct 27, 2020 10:00 am

Patent Suggests Apple Is Working on Smart Biomedical Glasses

It is commonly known that Apple is working on bettering its offerings in the wellness and health category. The company was recently awarded a patent that indicates that the firm is taking its approach into health a step further with a new invention: biomedical smart glasses. Spotted by Patently Apple, the new patent describes this invention as a head-mounted display device that can monitor certain head movements such as nodding one’s head as well as facial gestures such as closing and opening mouths. The device can also be used with other health devices, including the Apple Watch. This ability will…

Continue Reading

MondayOct 26, 2020 12:00 pm

Is It Acceptable for Police to Seize Your Biomedical Samples?

Let’s assume you’ve acquired a grant to begin a research study to investigate the spread of a certain disease in a population. So you gather your samples, do your research and publish your findings. Then out of nowhere, law enforcement shows up with a court order to obtain a sample from your collection that will  help in the legal prosecution of one of the participants of your study. As a researcher, would you find it unethical for the police to take your research samples without the participants’ consent or knowledge? In an essay authored by Nina de Groot and her…

Continue Reading

MondayOct 26, 2020 10:00 am

Study Discovers Global Distrust for COVID-19 Vaccines

A research team made up of researchers from the City University of New York Graduate School of Public Health and Health Policy (CUNY SPH) and other distinguished institutions such as the Barcelona Institute for Global Health and the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine announced yesterday that their research, which focused on potential global hesitancy to accept a coronavirus vaccine, was published in the “Nature Medicine” journal. The researchers carried out their research based on previously collected COVID-SCORE data of more than 13,400 people from 19 countries that had been the most affected by…

Continue Reading

FridayOct 23, 2020 3:08 pm

SPAC Merger Fires Boosters for 180 Life Sciences’ Exploration in Unmet Medical Needs of Anti-inflammatories Space

Biotechnology company 180 Life Sciences has launched a variety of advanced clinical and preclinical-stage efforts to develop novel anti-inflammatory treatments for patients with chronic illnesses A planned merger with 180 Life Sciences advanced under a special purpose acquisition corporation (SPAC) is expected to be completed within the next month, resulting in a Nasdaq filing under the ticker ATNF 180 Life Sciences’s founders are an experienced team of medical scientists who pioneered anti-inflammatory pharmaceuticals in the 1990s that are still in use today, generating billions in revenue The company’s own-IP clinical trials seek to resolve inflammation-related issues in conditions such as…

Continue Reading

FridayOct 23, 2020 1:05 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Moves Closer to IND Filing as Manufacturing of Lead Drug Candidate Commences

Berubicin Expected to Commence Trials for the Treatment of Glioblastoma, An Aggressive Form of Brain Cancer Currently Considered Incurable Production of Berubicin Begins in the U.S. and Europe Dual Manufacturing Facilities Engaged to Reduce Supply Chain Interruptions IND for Berubicin Could Be Filed by Year End CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) expects to have an Investigational New Drug Application (“IND”) ready for its lead drug candidate, Berubicin, by the end of 2020. An approved IND would give the biotech company, which is developing treatments for primary and metastatic cancers of the brain and central nervous system, the green light to…

Continue Reading

FridayOct 23, 2020 12:00 pm

Social Distancing, Masks May Not Be Enough to Prevent Coronavirus Infection

When the pandemic began, many countries introduced guidelines to help curb the spread of the coronavirus. The most common of these included: 1.  Social distancing 2. Avoiding crowds; limiting the number of people in public places 3. Wearing a mask in public However, these recommendations are based on decades-old scientific foundations that may not reflect the current state of knowledge. Consequently, several research groups have come together to develop a better and improved model of the spread of the disease’s infectious droplets. These researchers from the field of fluid dynamics have demonstrated that while it makes sense to maintain social…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000